Search results
Showing 1 to 4 of 4 results for filgrastim
Talazoparib for treating HER2-negative advanced breast cancer with germline BRCA mutations (TA952)
Evidence-based recommendations on talazoparib (Talzenna) for HER2-negative, locally advanced or metastatic breast cancer with germline BRCA1 or BRCA2 mutations in adults.
Leukaemia (acute myeloid, relapsed, refractory) - vosaroxin [ID746]
Discontinued [GID-TA10070]
Quizartinib for treating relapsed or refractory acute myeloid leukaemia [ID1325]
Discontinued [GID-TA10363]
Evidence-based recommendations on olaparib (Lynparza) for previously treated BRCA mutation-positive hormone-relapsed metastatic prostate cancer in adults.